Paratek Pharmaceuticals News

PRTKDelisted Stock  USD 2.18  0.00  0.00%   
About 56% of Paratek Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Paratek Pharmaceuticals suggests that many traders are alarmed regarding Paratek Pharmaceuticals' prospects. Paratek Pharmaceuticals' investing sentiment shows overall attitude of investors towards Paratek Pharmaceuticals.
  
over a year ago at www.macroaxis.com         
Disposition of 622284 shares by Adam Woodrow of Paratek Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Antimicrobial Resistance Market to Reach 9.5 Billion, Globally, by ... - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Second Leading Independent Proxy Advisory Firm Glass Lewis ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates HCCI, KLR, PRTK - Heritage-Crystal Clean NAS...
Google News at Macroaxis
over a year ago at news.google.com         
Insomnia Therapeutics Drugs Market Size 2023 Details such as revenues, market share - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
Sleeping Pills Market Size and Trend Analysis 2023-2030 Poised for Strong Growth in Future - Benzing...
Google News at Macroaxis
over a year ago at news.google.com         
Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Paratek Pharmaceuticals Coverage Initiated by Analysts at StockNews.com
news
over a year ago at thelincolnianonline.com         
Paratek Pharmaceuticals Share Price Crosses Above 200 Day Moving Average of 2.06
news
over a year ago at thelincolnianonline.com         
StockNews.com Initiates Coverage on Paratek Pharmaceuticals
news
over a year ago at news.google.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates CEQP, CELL, DINO, PRTK - PhenomeX , - Benzin...
Google News at Macroaxis
over a year ago at benzinga.com         
SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of th...
benzinga news
over a year ago at news.google.com         
Methicillin-Resistant Staphylococcus Aureus Drugs Global ... - MENAFN.COM
Google News at Macroaxis
over a year ago at news.google.com         
Acute Bacterial Skin and Skin Structure Infections Market to Grow Substantially by 2032, Assesses De...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Paratek Pharmaceuticals Receives New Coverage from Analysts at StockNews.com
news
Far too much social signal, news, headlines, and media speculation about Paratek Pharmaceuticals that are available to investors today. That information is available publicly through Paratek media outlets and privately through word of mouth or via Paratek internal channels. However, regardless of the origin, that massive amount of Paratek data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Paratek Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Paratek Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Paratek Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Paratek Pharmaceuticals alpha.

Paratek Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Paratek Pharmaceuticals Halted, News Pending
06/06/2023
2
NexPoint Asset Management Sends Open Letter to the Board of Paratek Pharmaceuticals Regarding Upcoming Annual Meeting and Proposed Acquisition by Gurnet Point C...
06/27/2023
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Paratek Stock

If you are still planning to invest in Paratek Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paratek Pharmaceuticals' history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies